Advertisement
The Lancet Healthy Longevity Home

About The Lancet Healthy Longevity

About the journal

The Lancet Healthy Longevity is gold open access, multi-disciplinary journal that publishes clinically-focused longevity and healthy ageing research and review. The broad research remit aims to encompass early-stage clinical research into the mechanisms of ageing through to epidemiological and societal research on changing populations, including clinical trials in all disciplines focused on older people, gerontological science, and age-specific clinical guidelines.

The journal will also publish clinical and policy reviews which aim to shape and contextualise the debate on this fast-growing discipline. The Lancet Healthy Longevity will continue in the Lancet family tradition of being a strong advocate for the rights of all people to healthy, fulfilling lives, irrespective of age, and prioritises reports of original research that are likely to change clinical practice or thinking.

Find out about The Lancet Healthy Longevity - hear from Editor-in-Chief, Cassandra Coburn

Information for Authors

In keeping with other Lancet journals, The Lancet Healthy Longevity offers rapid publication of research online within 8–12 weeks from submission. Wherever possible, figures and good quality photographs should be used to supplement and to enhance the text. We also welcome videos. All original research is subjected to the Lancet family of journals' usual rigorous standards of external clinical and statistical peer review, and edited by experienced technical copy editors to the highest standards.

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

We also welcome pre-submission enquiries. To find out more please contact: [email protected]

Article processing charges

No subscription or pay-per-view charges apply to any content published in The Lancet Healthy Longevity. In order to cover the costs of reviewing, copy editing, layout, and online hosting and archiving, the journal charges an article processing fee of $5000 upon acceptance of submitted research articles (no fee applies to Comment or Correspondence).

Authors whose main funder is located either in group A or B countries of the Health Inter Network Access to Research Initiative (HINARI) or in a country with a low UNDP human development index will be exempt from payment. For authors with no formal funding, the country of origin of the majority of authors' institutions will be taken as the source country. If there is no majority country, the corresponding author's country will be so designated.

The editorial decision to accept is taken well before any request is made as to the ability to pay. Payments are processed by a department unconnected to The Lancet Healthy Longevity's editorial department.

Copyright and reuse

All content is published under Creative Commons licensing, which enables authors to retain copyright while allowing others to copy, distribute, and make some uses of their work, provided full credit is given to them as originators. Authors will be offered a choice of two licences (CC BY or CC BY-NC-ND) depending on whether or not they wish to allow commercial reuse of their work and whether or not they wish to allow others to alter their work in the course of its reuse. Authors will be asked to sign a licence to permit our publisher, Elsevier, to publish the work in The Lancet Healthy Longevity.

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About the Editorial team

Cassandra Coburn, Editor-in-chief

Cassandra Coburn, Editor-in-Chief
Cassandra obtained her PhD in Genetics from the Institute of Healthy Ageing at University College London, UK. She joined The Lancet in 2013, first as a Senior Editor at The Lancet Oncology, before being promoted to Deputy Editor at the same journal. During this first stint at The Lancet, Cassandra also held the post of Acting Executive Editor of The Lancet Haematology. In 2018, she left the group to write a popular science book, ENOUGH, which addressed the intersection between preventative medicine, the environment, and nutrition (Hachette, Jan 2021). Returning to The Lancet in 2020, Cassandra became the founding Editor-in-Chief of The Lancet Healthy Longevity.

Sophie Raeder, Senior Editor

Dr. Sophie Raeder, Senior Editor
Sophie completed her PhD in Psychiatry at the Oxford Centre for Human Brain Activity at the University of Oxford. Her research investigated attentional biases in anxious adults, in particular comparing biases between young and older adults. She thereafter joined the UCL Unit for Stigma Research as a postdoctoral research fellow. Her research interests include anxiety, old age psychiatry, mental health stigma, and developing new methods for improving mental health in vulnerable groups.

About the advisory board

The international advisory board consists of key opinion leaders and researchers from around the world who will lend their expertise to this journal. We are very grateful for their support and advice on editorial matters.

The Lancet Group’s Diversity Pledge and No All-Male Panel Policy

Read the Diversity Pledge and No All-Male Panel Policy

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

October 2020
Volume 1, Issue 1